(ADUS) Addus HomeCare - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0067391062
ADUS: Personal Care, Hospice, Home Health
Addus HomeCare Corporation (NASDAQ:ADUS) operates in the critical segment of home healthcare, providing essential services to the elderly, chronically ill, and disabled. Their services span three key areas: Personal Care, Hospice, and Home Health, each addressing distinct patient needs. The Personal Care segment focuses on non-medical assistance, including daily living activities, while Hospice offers palliative care for terminally ill patients. The Home Health segment provides skilled medical care, crucial for recovery post-hospitalization.
As a player in the healthcare services industry, Addus is strategically positioned to benefit from the growing demand for cost-effective, home-based care. Their services are reimbursed by government agencies, managed care organizations, and private payors, highlighting their integral role in the healthcare system. Founded in 1979 and headquartered in Frisco, Texas, Addus has established a strong presence with a market cap of approximately $2.05 billion.
Financially, Addus presents an interesting profile with a trailing P/E of 25.91 and a forward P/E of 19.01, indicating expectations of future growth. The price-to-book ratio of 2.21 suggests the market values their assets and potential. With a price-to-sales ratio of 1.81, investors may consider the companys revenue generation efficiency.
For investors, Addus represents a strategic investment in a sector poised for growth due to aging demographics and the shift towards home healthcare. Their diversified service offerings and cost-effective care model position them well to capitalize on these trends, making them a compelling consideration for those looking to invest in healthcare services.
Additional Sources for ADUS Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ADUS Stock Overview
Market Cap in USD | 1,763m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 2009-10-28 |
ADUS Stock Ratings
Growth 5y | 39.3% |
Fundamental | 40.3% |
Dividend | 0.0% |
Rel. Strength Industry | -8.73 |
Analysts | 4.5/5 |
Fair Price Momentum | 76.23 USD |
Fair Price DCF | 105.70 USD |
ADUS Dividends
No Dividends PaidADUS Growth Ratios
Growth Correlation 3m | -78.4% |
Growth Correlation 12m | 37.6% |
Growth Correlation 5y | 36.6% |
CAGR 5y | 11.22% |
CAGR/Max DD 5y | 0.25 |
Sharpe Ratio 12m | -0.22 |
Alpha | -18.60 |
Beta | 1.00 |
Volatility | 32.39% |
Current Volume | 207.7k |
Average Volume 20d | 240.1k |
As of March 15, 2025, the stock is trading at USD 90.28 with a total of 207,734 shares traded.
Over the past week, the price has changed by -6.96%, over one month by -20.26%, over three months by -30.77% and over the past year by -7.92%.
Partly, yes. Based on ValueRay Fundamental Analyses, Addus HomeCare (NASDAQ:ADUS) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 40.33 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ADUS as of March 2025 is 76.23. This means that ADUS is currently overvalued and has a potential downside of -15.56%.
Addus HomeCare has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy ADUS.
- Strong Buy: 8
- Buy: 3
- Hold: 0
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, ADUS Addus HomeCare will be worth about 84.1 in March 2026. The stock is currently trading at 90.28. This means that the stock has a potential downside of -6.9%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 136.3 | 50.9% |
Analysts Target Price | 137.8 | 52.7% |
ValueRay Target Price | 84.1 | -6.9% |